Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Inherited gene change also found in spontaneous tumors

10.10.2005


New research shows that a small gene variation that increases the risk of inherited cancer can also arise during the development of spontaneous, or non-inherited, tumors.



The findings, published in the Oct. 5 issue of the Journal of the American Medical Association, suggest that the variation might play a fundamental role in the development and spread of cancer in the body, and that the variant could be an important target for anticancer drugs.

The research focused on the gene for type 1 transforming growth factor-beta receptor, or TGFBR1, and on a variation of that gene, TGFBR1-6A. The 6A variant can be inherited and can increase cancer susceptibility by 19 percent in individuals with one copy of the gene and by 70 percent in those carrying two copies.


The study showed that the 6A variant, which is carried by nearly one in seven Americans generally and by one in six people with cancer, can also arise as a gene mutation during cancer development.

The research was led by scientists at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University .

“Our findings show for the first time that the 6A variation of this gene also arises by mutation during tumor development in patients born with the normal TGFBR1 gene, and that this mutation may contribute to tumor growth and spread,” says principal investigator Christopher M. Weghorst, an associate professor with the OSU School of Public Health and a researcher with the Comprehensive Cancer Center.

Furthermore, the researchers found the 6A variant in half of the metastatic liver tumors they examined. These tumors had spread to the liver from the colon.

In some cases, the variants in these tumors had been inherited, but, says lead author Boris Pasche, assistant professor of medicine at Northwestern University , “the majority of the liver metastases had acquired the variant as a mutation during cancer progression. This shows the dramatic impact of this gene on the growth of cancer cells in humans, and suggests that this molecule may become an excellent target for new therapies for patients with colorectal cancer, especially those with liver metastases.”

The findings also provide insights into the effects of the signaling molecule transforming growth factor beta. Transforming growth factor beta normally slows the growth of cells known as epithelial cells, and may stimulate the growth of cancerous epithelial cells. (Epithelial cells line the ducts, passages and hollow organs of the body and are the cells in which most cancers arise.)

This signaling molecule works by docking with TGFBR1, which is located on the surface of cells. Normally, the joining of the two molecules tells the cell to stop growing.

This new research indicates, however, that if the normal TGFBR1 gene mutates, causing a cell to have the TGFBR1-6A variant on its surface, the signaling molecule enables the cell to start growing and helps the growing tumor to metastasize.

For this study, Weghorst, Pasche and a group of colleagues looked for the 6A gene variation in tumor tissue from 226 patients with head and neck cancer, 157 patients with primary colorectal cancer, 104 patients with breast cancer and 44 patients with liver metastases from colorectal cancer.

They found the 6A variant in 2.5 percent of primary colorectal tumors and 1.8 percent of head and neck primary tumors, and in 29.5 percent of the tumors that had metastasized to the liver. The tumors had acquired the variant as a mutation. The variant was not found as a mutation in the breast tumors.

“We believe that the presence of the 6A variant places an individual at greater risk for developing some type of cancer compared with someone without the variant, and that this has important public health implications,” Weghorst says.

Overall, the evidence from the study suggests that the 6A mutation boosts cancer-cell growth and tumor metastasis. This, in turn, suggests that the molecule would make a good target for anticancer drugs that block the action of the 6A molecule.

Funding from the National Cancer Institute, the National Institute of Dental and Craniofacial Research, the Illinois Chapter of the American Cancer Society, the Walter S. Mander Foundation, The V Foundation, the Dutch Cancer Society and the Netherlands Organization for Scientific Research supported this research.

Darrell E. Ward | EurekAlert!
Further information:
http://www.osumc.edu

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>